S11 - "Best of" Session: Epilepsy/Clinical Neurophysiology (EEG)

Event Time: Monday April 23, 2018 8:00 am to 9:00 am
Topic(s): Epilepsy/Clinical Neurophysiology (EEG)
Description: A platform session that brings together the top four scoring abstracts in a particular topic, as rated by the topic reviewers. Offers an opportunity to interact with the author at the conclusion of the session.
Completion Message:
CME Credits: 1
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
8:00 AM 001 Maintaining Seizure Freedom during Pregnancy and Postpartum: Findings from the MONEAD Study Page Pennell, MD
Dr. Pennell has nothing to disclose.

8:08 AM 002 A Practical Risk Score for EEG Seizures in Hospitalized Patients Aaron Struck, MD
Dr. Struck has nothing to disclose.

8:16 AM 003 Seizure Semiologies and Effects of Anti-epileptic Drugs in Patients with Leucine-rich glioma-inactivated-1 ligand antibody (LGI1-Ab) Autoimmune Epilepsy Christopher Lamb, MD
Dr. Lamb has nothing to disclose.

8:24 AM 004 Interictal Spike Rates Are Correlated with Verbal Memory in Patients with Mesial Temporal Lobe Epilepsy Kimford Meador, MD, FAAN
Dr. Meador has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Consultant for the non-profit Epilepsy Study Consortium that receives monies from multiple pharmaceutical companies. Dr. Meador has consulted for the Epilepsy Study Consortium for the following companies: Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, UCB Pharma and Vivus Pharmaceuticals. In addition, he is Co-I and Director of Cognitive Core of the Human Epilepsy Project for the Consortium. Note that the Epilepsy Study Consortium pays Dr. Meador’s university for his consultant time.. Dr. Meador has received research support from Sunovion.

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses